ITERION THERAPEUTICS INC.
Biotech · Private
Nebulized small molecule Wnt/β-catenin signaling inhibitor (BC-2059) for pulmonary fibrosis treatment
- Grants
- $300K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 23
- 10 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Chronic intrapulmonary delivery of a novel small molecule Wnt/beta-catenin inhibitor for Idiopathic Pulmonary Fibrosis | $299,974 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2671 | Paralos Bioscience Inc. | — | $50K |
| 2672 | POTOMAC AFFINITY PROTEIN LLC | — | — |
| 2673 | Advanced Gene Transfer Company, Inc. | — | — |
| 2674 | ITERION THERAPEUTICS INC. | — | — |
| 2675 | Qu Biologics Inc. | — | $49K |
| 2676 | Sequence46, LLC | — | $48K |
| 2677 | Forkhead Biotherapeutics, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods For Treatment Of Fibrotic Diseasesapplication
- Formulations Of Tegavivintapplication
- Formulations Of Tegavivintgranted
- Crystalline Form Of Tegavivint, Method Of Preparation, And Use Thereofapplication
- Formulations Of Tegavivint And Related Compoundsapplication
- Lyophilized Formulations Of Tegavivintapplication
- Crystalline Form Of Tegavivint, Method Of Preparation, And Use Thereofgranted
- Formulations Of Tegavivint And Related Compoundsgranted
- Lyophilized Formulations Of Tegavivintgranted
- Formulations Of Tegavivintgranted
- Lyophilized Formulations Of Tegavivintgranted
- Lyophilized Formulations Of Tegavivintgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.